UTHR-a Promising Biotech in the works here? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : UTHR-a Promising Biotech in the works here?

UTHR 445.43

-1.8%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kendall harmon who started this subject	8/9/2001 2:15:03 PM
From: Doc Bones	Read Replies (1) of 66

UTHR drug Remodulin approved by FDA (Unexpectedly) BRIEFING.COM: 13:22 ET United Thera (UTHR) 8.81 unch: Reports coming in that an FDA panel has voted to recommend approval of company's lung drug. UTHR shares were halted for trading ahead of the meeting. ---- A YAHOO MESSAGE: Reading the statisticians report, I would have NEVER guessed it. They said they failed to meet their efficacy targets. All I've seen is the Reuters and Dow Jones reports, We'll have to see what kind of restrictive comments they might have made. Congratulations to all of the gutsy longs. No position in UTHR for me. Huge ---- REUTERS: FDA panel backs United Therapeutics' Remodulin BETHESDA, Md., Aug 9 (Reuters) - A U.S. advisory panel on Thursday backed United Therapeutics Corp.'s (NasdaqNM:UTHR - news) drug Remodulin for treating a chronic, life-threatening lung condition called pulmonary hypertension. A Food and Drug Administration advisory committee voted 6-3 that Remodulin should be approved for treating the condition, which afflicts about 100,000 people worldwide

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next